Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the treatment of type 2 diabetes. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally https://elijahskpj211598.smblogsites.com/39082361/semaglutide-a-potential-solution-for-diabetes